Heather Sadlish

Heather comes to Rgenta with 16 years of drug discovery experience in both a successful start-up and an international pharmaceutical setting. Prior to Rgenta, Heather was at Yumanity Therapeutics where she led the Target Discovery team through prioritization and validation efforts to identify novel modulators of neurodegenerative disease. She also developed in vitro translational models and drove pre-clinical efforts for lead programs. Prior to Yumanity, Heather was at the Novartis Institute of Biomedical Research in Basel, Switzerland. There, she helped build a world-class chemogenomic profiling platform to elucidate small molecule mechanisms of action, as well as lead multiple projects through early target validation.